Prognose

Kaufen	2
Halten	0
Verkaufen	0

Scoring-Modelle

Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.

News

SenesTech Announces Closing of Warrant Exercise for $4.4 Million in Gross Proceeds
SURPRISE, Ariz. , July 1, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), a leader in fertility control for managing animal pest populations, announced today the closing of its previously announced exercise of certain outstanding warrants to purchase an aggregate of 1,458,872 shares of the Company's common stock originally issued by the Company on March 11, 2025, at the existing exercise price of $2.90 per share.» Mehr auf prnewswire.com
SenesTech Announces Warrant Exercise for $4.4 Million in Gross Proceeds
SURPRISE, Ariz. , July 1, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), a leader in fertility control for managing animal pest populations, announced today the entry into definitive agreements for the immediate exercise of certain outstanding warrants to purchase an aggregate of 1,458,872 shares of the Company's common stock originally issued by the Company on March 11, 2025, at the existing exercise price of $2.90 per share.» Mehr auf prnewswire.com
SenesTech's Evolve™ Rodent Birth Control Proven in Urban Rodent Hotspots from Hong Kong to San Francisco
Pallet and Container Orders Expected for Resupply and Expansion SURPRISE, Ariz. , June 26, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), a leader in fertility control for managing animal pest populations, today announced compelling results from two major urban deployments — one in Hong Kong and one in San Francisco — showing how pairing Evolve™ Rat Birth Control with traditional poison bait stations delivers faster, more sustainable rodent control where it's needed most.» Mehr auf prnewswire.com

Unternehmenszahlen

Im letzten Quartal hatte SenesTech Aktie einen Umsatz von 448,31k€ und ein Nettoeinkommen von 0,00€

(EUR)	März 2025	YOY
Umsatz	+448,31k	16,59%
Bruttoeinkommen	+289,32k	218,62%
Nettoeinkommen	0,00	100,00%
EBITDA	−1,54 Mio	7,37%

Fundamentaldaten

Metrik	Wert
Marktkapitalisierung	+7,92 Mio€
Anzahl Aktien	1,81 Mio
52 Wochen-Hoch/Tief	+5,52€ - +1,11€
Dividenden	Nein
Beta	-0,08
KGV (PE Ratio)	−1,54
KGWV (PEG Ratio)	−0,07
KBV (PB Ratio)	+2,31
KUV (PS Ratio)	+4,82

Unternehmensprofil

SenesTech, Inc. entwickelt eine Technologie zur Kontrolle von Tierschädlingspopulationen durch Fruchtbarkeitskontrolle. Es bietet ContraPest an, einen Flüssigköder, der die Fortpflanzung von männlichen und weiblichen Ratten einschränkt. Das Unternehmen wurde im Jahr 2004 gegründet und hat seinen Hauptsitz in Phoenix, Arizona.